Upgrade to SI Premium - Free Trial

Sarepta Therapeutics (SRPT) PT Raised to $25 at Morgan Stanley

March 25, 2026 3:05 PM
Morgan Stanley analyst Matthew Harrison raised the price target on Sarepta Therapeutics (NASDAQ: SRPT) to $25.00 (from $20.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles